Acadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc.

710.00
MXN
+229.42
(+47.74%)
-222.35EPS
45.23BMarket Cap
Mar 01Next Earn

Total Valuation

MXN

As of September 30, 2026, Acadia Healthcare Company, Inc. carries a market capitalization of 45.23B, placing it among publicly traded companies globally. Its enterprise value stands at 91.66B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap45.23B
Enterprise Value91.66B

Important Dates

Acadia Healthcare Company, Inc.'s next confirmed earnings release is scheduled for March 1, 2027.

Earnings Date3/1/2027

Share Statistics

As of September 30, 2026, Acadia Healthcare Company, Inc. has 90.91M shares outstanding.

Shares Outstanding90.91M

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 0.73, and the price-to-book ratio stands at 1.24.

PS Ratio0.73
PB Ratio1.24
P/TBV Ratio4.13
P/FCF Ratio10.67
P/OCF Ratio10.62

Enterprise Valuation

These figures are as of September 30, 2026. The EV/Sales ratio of 1.49 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 91.66B versus a market cap of 45.23B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales1.49

Financial Position

As of September 30, 2026, Acadia Healthcare Company, Inc. maintains a current ratio of 1.60, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 111.20, indicating elevated leverage, while an interest coverage ratio of -4.79 demonstrates limited ability to service its debt obligations.

Current Ratio1.60
Quick Ratio1.31
Debt / Equity111.20
Debt / EBITDA-3.45
Interest Coverage-4.79

Financial Efficiency

MXN

Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. posted a negative return on equity (ROE) of -43.87, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -18.85, reflecting losses generated across the asset base. The company generates approximately 2.46M in revenue per employee across its workforce of 25,000.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 19.52 indicates how many times Acadia Healthcare Company, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-43.87
Return on Assets (ROA)-18.85
Revenue Per Employee2.46M
Employee Count25,000.00
Inventory Turnover19.52

Taxes

MXN

Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. recorded 756.74M in income tax expense. The company reported a pretax loss of -19.50B and -20.37B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax756.74M

Stock Price Statistics

As of the close on November 10, 2026, Acadia Healthcare Company, Inc.'s stock has gained approximately 93.99% over the past 52 weeks.

52-Week Price Change93.99%

Income Statement

MXN

Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. generated 61.60B in revenue and converted that into -20.37B in net income, yielding earnings per share of -222.35. EBITDA reached -13.12B, while operating income came in at 6.02B.

Revenue61.60B
Gross Profit59.40B
Operating Income6.02B
Pretax Income-19.50B
Net Income-20.37B
EBITDA-13.12B
EBIT-16.76B
Earnings Per Share (EPS)-222.35

Balance Sheet

MXN

As of September 30, 2026, Acadia Healthcare Company, Inc. holds 2.95B in cash and equivalents against 45.23B in total debt, resulting in a net debt position of 39.53B. Total book value stands at 36.52B, with working capital of 5.95B providing operational flexibility.

Cash & Cash Equivalents2.95B
Total Debt45.23B
Net Debt39.53B
Equity (Book Value)36.52B
Book Value Per Share401.71
Working Capital5.95B

Cash Flow

MXN

Acadia Healthcare Company, Inc. produced 4.25B in operating cash flow over the twelve months ended September 30, 2026.

Operating Cash Flow4.25B
Free Cash Flow4.25B
FCF Per Share46.84

Margins

Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. posted a gross margin of 96.43, reflecting its pricing power and cost economics. The operating margin of 9.77 and net profit margin of -33.07 provide insight into operational efficiency.

Gross Margin96.43
Operating Margin9.77
Pretax Margin-31.66
Profit Margin-33.07
EBITDA Margin-21.30

Dividends & Yields

These figures cover the twelve months ended September 30, 2026. Free cash flow yield stands at 9.37, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -1.49, meaning Acadia Healthcare Company, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-1.49
FCF Yield9.37

Stock Splits

Acadia Healthcare Company, Inc.'s most recent stock split took place on November 1, 2011 with a 4:1 split ratio.

Last Split Date11/1/2011
Split Ratio4:1

Scores

As of September 30, 2026, Acadia Healthcare Company, Inc. has an Altman Z-Score of 1.40, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.40